# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-042025
Filing Date
2025-05-12
Accepted
2025-05-12 16:06:07
Documents
60
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | ea0238635-10q_relmada.htm iXBRL | 10-Q | 450636
2 | EXCLUSIVE LICENSE AGREEMENT BETWEEN TRIGONE PHARMA, LTD., AND RELMADA THERAPEUTI | ea023863501ex10-2_relmada.htm | EX-10.2 | 270646
3 | CERTIFICATION | ea023863501ex31-1_relmada.htm | EX-31.1 | 11211
4 | CERTIFICATION | ea023863501ex31-2_relmada.htm | EX-31.2 | 10979
5 | CERTIFICATION | ea023863501ex32-1_relmada.htm | EX-32.1 | 4853
6 | CERTIFICATION | ea023863501ex32-2_relmada.htm | EX-32.2 | 4340
| Complete submission text file | 0001213900-25-042025.txt |  | 4126950

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | rlmd-20250331.xsd | EX-101.SCH | 35069
8 | XBRL CALCULATION FILE | rlmd-20250331_cal.xml | EX-101.CAL | 23783
9 | XBRL DEFINITION FILE | rlmd-20250331_def.xml | EX-101.DEF | 190922
10 | XBRL LABEL FILE | rlmd-20250331_lab.xml | EX-101.LAB | 340684
11 | XBRL PRESENTATION FILE | rlmd-20250331_pre.xml | EX-101.PRE | 204219
62 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0238635-10q_relmada_htm.xml | XML | 294119

Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39082 | Film No.: 25934760
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)